Market Tracker

02/05 5:16pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

2.92
Delayed Data
As of Feb 05
 +0.07 / +2.46%
Today’s Change
2.58
Today|||52-Week Range
7.43
-17.51%
Year-to-Date

Today’s Trading

Previous close2.85
Today’s open2.85
Day’s range2.83 - 2.96
Volume2,695,705
Average volume (3 months)3,354,262
Market cap$466.2M
Dividend yield6.85%
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+4.12%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio1.8
Price/Sales2.30
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
SGNTSagent Pharmaceutica...-0.09-0.62%
ENTAEnanta Pharmaceutica...-1.21-5.05%
TGTXTG Therapeutics Inc-0.10-1.16%
COLLCollegium Pharmaceut...-0.52-2.70%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 29, 2016
EPS forecast (this quarter)$0.54
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

Chart unavailable